Author's posts
CAR T Therapy, A Promising New Therapy For Multiple Sclerosis?
A recent study of mice suggests CAR T therapy may provide a new way to treat and potentially cure multiple sclerosis.
New Insights Into The Postfusion Structure Of SARS-CoV-2 Spike Protein
A startling new structure of the SARS-CoV-2 spike protein sheds light on the critical first step of infection, fusion of the virus and cell membranes.
Successes Like The Covid-19 Vaccines Come From Long-Term Investments In Public Health
The Covid-19 vaccines have prevented more than 18 million additional hospitalizations and more than 3 million additional deaths in the United States alone but their success was only possible because of sustained investments in public health.
CAR T Therapy To Treat And Cure Rheumatoid Arthritis
One study progresses towards a cure for rheumatoid arthritis by using CAR T therapy, a treatment originally designed to fight cancer.
Reimagining Alzheimer’s (Part 7): Cholesterol Abnormalities May Contribute To Alzheimer’s Disease
This is the second story on how a novel aspect of the APOE4 genetic predisposition to Alzheimer’s was recently uncovered by a team at MIT and may lead to the potential for new diagnostic methods and treatments.
Extended Antigen Availability Improves Vaccine Protection
A growing body of research suggests giving the immune system more time to “learn” about a vaccine antigen improves immune memory, helping to keep us safe during reinfection.
The Fat Truth: You Feel It In Your Gut
In a world where fat is added to nearly every meal, the challenge many Americans face is how to cap their daily fat intake. Now, in a recent study, investigators argue that restricting fat cravings may be outside our conscious control.
Why The Covid Vaccines Work And How To Make Them Better
A new study reveals the integral role of spike conformation on neutralizing activity in vaccines, paving the way for advancements in the near future.
Covid-19 Treatments Like Paxlovid Are Being Underused
A recent CDC report notes that people over the age of 80 are less likely to receive Paxlovid than those under 65. A significant issue when those over 65 and especially those over 80 are making up a significant proportion of Covid-19 related deaths.
Teaming Up Two Biotech Winners to Fight Cancer: CRISPR and CAR T
Integration of CRISPR gene editing could improve the precision, speed and cost-effectiveness of cancer-fighting CAR T therapy
